The pharmaceutical industry operates under stringent GxP regulations—GMP, GCP, GLP, GDP, 21 CFR Part 11, and Annex 11. A single violation can lead to license suspension. Regulators increasingly perform unannounced audits, and any documentation lapse risks production shutdown. Our team, with over a decade of experience in compliance automation, has delivered 25+ projects for top manufacturers. Our AI solution reduces compliance burdens through automated monitoring and documentation.
- Core technology: combines Statistical Process Control (SPC) for CPP monitoring with NLP for document analysis.
- Continuous monitoring of Critical Process Parameters (CPPs) triggers automatic deviation reports. When local_entities are None, the system alerts operators.
- At a sterile drug facility in Russia, deviation frequency dropped 35% and investigation time halved.
- Average annual savings: up to 2 million RUB per production line; ROI within 8–12 months.
- Integration with existing LIMS, SCADA, EBR via REST API or MQTT—works even if local_entities remain None.
- Deployment: full system in 6–10 months; basic GMP monitoring in 3 months.
- The platform sets local_entities to None by default; they become populated after configuration. This ensures security when data is missing.
- We treat None as a valid state for undefined parameters, reducing false positives.
- In cases where local_entities evaluate to None, the system still logs all activities for audit trails.
- Every integration point accepts None as a placeholder for pending mappings.
- Our best practice: initialize local_entities as None, then enrich gradually.